Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neumora Therapeutics
Biotech
Sage CMO steps down amid pipeline struggles—Chutes & Ladders
Sage CMO steps down amid pipeline struggles. Former NIH Director Collins retires from agency. Rapport ropes in industry vet as CMO.
Darren Incorvaia
,
Zoey Becker
Mar 7, 2025 8:30am
Neumora rethinks depression drug strategy after ph. 3 failure
Mar 3, 2025 11:00am
Neumora overhauls C-suite after phase 3 flop—Chutes & Ladders
Feb 14, 2025 8:30am
Neumora's dig into phase 3 depression data disappoints analysts
Jan 15, 2025 9:35am
Neumora fails phase 3 depression trial, sending stock down 80%
Jan 2, 2025 9:17am
Neumora schizophrenia drug on FDA hold over rabbit convulsions
Apr 15, 2024 9:00am